OakChart

Merit Medical Systems Inc

MMSIHealthcare·Medical Instruments & Supplies·USA·Mid·NASD·Nov 11 • 3:59 PM ET

88.07+0.26 (0.30%)
2026-11-12 00:20 CET
Market cap
5,261.14 USD m
Revenue, TTM
1,612.95 USD m
Net income, TTM
160.12 USD m
Free cash flow, TTM
203.59 USD m
EPS diluted, TTM
2.66
P/E
33.06
Compare

Price

MMSI against its 20, 50 and 200-day averages
2050200beat
60.0070.0080.0090.001.5M3.0MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26MMSIclose 88.0720-day 89.9250-day 88.13200-day 77.1688.0752w high52w low

7.1% under the 52-week high of 94.85 on 26 Oct 2026. 52-week low 59.74 on 6 May 2026. Last 15 sessions, 13.5% high to low

Volume 0.63× normal · the line is the 50-bar volume average

Profile

MMSI
52-week range, 81% of the way up
59.7494.85

Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.

IndexRUT
Employees7500
IPOMay 14, 1990
Beta0.55
ATR, 14d2.78
Rel volume0.63
Short float6.85%
Insider own2.60%
Inst own107.97%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap5.28B
Enterprise Value5.59B
Income160.12M
Sales1.61B
Book/sh29.13
Cash/sh8.44
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees7500
IPOMay 14, 1990

Ratios

P/E33.06
Forward P/E18.87
PEG1.98
P/S3.27
P/B3.02
P/C10.43
P/FCF25.92
EV/EBITDA15.75
EV/Sales3.47
Quick Ratio3.05
Current Ratio4.52
Debt/Eq0.47
LT Debt/Eq0.47
Option/ShortYes / Yes

Earnings

EPS (ttm)2.66
EPS next Y4.67
EPS next Q1.11
EPS this Y13.60%
EPS next Y7.29%
EPS next 5Y9.53%
EPS past 3/5Y18.04% -
Sales past 3/5Y9.70% 9.46%
EPS Y/Y TTM33.77%
Sales Y/Y TTM9.34%
EPS Q/Q51.30%
Sales Q/Q8.49%
EarningsOct 29 AMC
EPS/Sales Surpr.7.76% 1.37%

Ownership

Insider Own2.60%
Insider Trans-1.91%
Inst Own107.97%
Inst Trans2.70%
ROA5.76%
ROE9.78%
ROIC6.26%
Gross Margin49.41%
Oper. Margin13.56%
Profit Margin9.93%
SMA20-2.06%
SMA50-0.06%
SMA20014.15%
Trades-

Technical

Shs Outstand59.90M
Shs Float58.36M
Short Float6.85%
Short Ratio5.74
Short Interest4.00M
52W High94.85 -7.15%
52W Low59.74 47.42%
Volatility3.51% 3.03%
ATR (14)2.78
RSI (14)48.29
Beta0.55
Rel Volume0.63
Avg Volume696.67K
Volume442,014

Performance

Perf Week-2.82%
Perf Month-0.08%
Perf Quarter-2.69%
Perf Half Y40.64%
Perf YTD-0.08%
Perf Year-1.48%
Perf 3Y26.46%
Perf 5Y29.61%
Perf 10Y282.91%
Recom1.77
Target Price107.00
Prev Close87.81
Price88.07
Change %0.30%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Feb 26, 2026DowngradeWWells FargoOverweight → Equal Weight$78-11.4%
Feb 06, 2026InitiatedBBTIG ResearchBuy$107+21.5%
Mar 28, 2025InitiatedJJP MorganOverweight$120+36.3%
Dec 11, 2024UpgradeWWells FargoEqual Weight → Overweight$103 → $120+36.3%
Jun 28, 2024InitiatedRRobert W. BairdOutperform$96+9.0%
Apr 11, 2024InitiatedCCL KingBuy$88-0.1%
Feb 07, 2024InitiatedBBofA SecuritiesNeutral$87-1.2%
Dec 21, 2023UpgradeCCanaccord GenuityHold → Buy$100+13.5%
Dec 20, 2022DowngradeCCanaccord GenuityBuy → Hold$73 → $72-18.2%
Jan 05, 2021UpgradeNNeedhamHold → Buy$65-26.2%

Peers

Mkt cap
TickerCompanyMkt cap
TFXTeleflex Incorporated6.20B
BDXBecton Dickinson & Co58.43B
ANGOAngiodynamic Inc522.32M
ICUIICU Medical Inc4.46B
LMATLemaitre Vascular Inc1.81B
BSXBoston Scientific Corp65.41B
PENPenumbra Inc12.68B
ITGRInteger Holdings Corp4.31B
CNMDConmed Corp1.51B
MDTMedtronic Plc129.98B

Insider trading

latest 14 of 23
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Peterson Neil W.CHIEF OPERATING OFFICERAug 24 '26Sale90.457,500678,36018,051Aug 25 04:43 PM
NEIL W PETERSONOfficerAug 24 '26Proposed Sale90.457,500678,360Aug 24 04:07 PM
Peterson Neil W.CHIEF OPERATING OFFICERAug 04 '26Sale85.0021,4491,823,16525,551Aug 05 01:22 PM
NEIL W PETERSONOfficerAug 04 '26Proposed Sale85.0021,4491,823,165Aug 04 04:10 PM
Gunderson Thomas J.DirectorMay 20 '26Option Exercise52.1721,2501,108,61260,741May 21 09:10 AM
Smith Christian AdamChief Commercial OfficerMay 11 '26Buy61.001,62699,1862,220May 13 01:19 PM
Ward Lynne N.DirectorMay 07 '26Sale62.615,000313,0357,809May 11 01:04 PM
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARYMay 07 '26Buy62.622,000125,2502,000May 11 01:03 PM
Aronson Martha GoldbergPresident and CEOMay 06 '26Buy60.442,000120,88049,792May 07 04:12 PM
LYNNE WARDDirectorMay 07 '26Proposed Sale62.615,000313,036May 07 04:11 PM
Parra Raul Jr.CFO AND TREASURERMay 06 '26Buy61.011,50091,51558,843May 07 04:09 PM
Voigt Michel J.CHIEF HUMAN RESOURCES OFFICERMay 05 '26Buy60.652,250136,4622,265May 07 04:07 PM
Peterson Neil W.CHIEF OPERATING OFFICERJan 06 '26Option Exercise54.405,000272,00033,369Jan 08 12:57 PM
Peterson Neil W.CHIEF OPERATING OFFICERJan 06 '26Sale90.005,000450,00028,369Jan 08 12:57 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
VXFVanguard Extended Market Index ETFAUM: 30.47B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
DFATU.S. Targeted Value Portfolio-ETF Class SharesAUM: 14.47B

News

latest 14 of 200
  • Merit Medical Presents Real-World Data from the AVF Cohort of the WRAP Global Registry (GlobeNewswire)
  • Merit Medical Misses On Normalized EPS But Raises Guidance A Third Time As 9% Organic Growth Holds; Gross Margin Slippage Is The Crack (Earnings Whispers) -7.66%
  • Merit Medical: Q3 Earnings Snapshot (Associated Press)
  • Merit Medical Reports Third Quarter 2026 Results: Delivers 9% Organic Constant Currency Revenue Growth and Raises Full-Year 2026 Guidance (GlobeNewswire)
  • Merit Medical Acquires Solo Pace, Inc., Expanding Its Cardiac Therapies Platform with Innovative TAVR Pacing Technology (GlobeNewswire)
  • Merit Medical Must Prove Its Record Second Quarter Was A New Baseline (Earnings Whispers)
  • Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026 (GlobeNewswire)
  • Merit Medical to Participate in Upcoming Investors Conferences in September (GlobeNewswire)
  • Merit Medical Announces Global Operations Leadership Transition (GlobeNewswire)
  • Merit Medical to Participate in Upcoming Investors Conferences in August (GlobeNewswire)
  • Merit Medical Systems Inc (MMSI) (Q2 2026) Earnings Call Highlights: Strongest Organic Growth ... (GuruFocus.com)
  • Merit Medical: Q2 Earnings Snapshot (Associated Press)
  • Merit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 Guidance (GlobeNewswire)
  • Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026 (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-291.1201.0390.700416.2410.5611
2026Q22026-07-301.1900.9590.647418.84405.2510
2026Q12026-04-300.9400.8330.683381.88377.5910
2025Q42026-02-241.0400.9540.633393.94389.9410
2025Q32025-10-300.9200.8280.463384.2371.929
2025Q22025-07-301.0100.8510.538382.46374.1510
2025Q12025-04-240.8600.7490.492355.35352.5410
2024Q42025-02-250.9300.8290.461355.16351.629
2024Q32024-10-300.8600.7980.478339.85334.610
2024Q22024-08-010.9200.8740.608338334.5610
2024Q12024-04-300.7700.7140.482323.51315.579
2023Q42024-02-280.8100.7660.473324.52320.668
2023Q32023-10-260.7500.6470.443315.23306.197
2023Q22023-07-250.8100.7520.346320.06310.17
2023Q12023-04-260.6400.5460.356297.6280.57
2022Q42023-02-220.7900.6710.576293.42290.147

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY1.4601.4130.097994.85989.22
2020FY1.6501.556-0.178963.88956.32
2021FY2.3702.1730.8451,0751,067
2022FY2.7002.5761.2921,1511,148
2023FY3.0102.9711.6181,2571,253
2024FY3.4603.3612.0271,3571,353
2025FY3.8303.7502.1301,5161,512
2026FY-4.351--1,639
2027FY-4.668--1,740
2028FY-5.032--1,840
2029FY-5.165--1,954
2030FY-5.530--2,069

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-301202422.77421.18429.3
2026Q4S2026-10-291200425.38421.34429.3
2026Q4S2026-10-261200425.38421.34429.3
2026Q4S2026-10-141100425.03421.34427.34
2026Q4S2026-08-171121425.03421.34427.34
2026Q4S2026-08-101121425.1421.34427.34
2026Q4S2026-08-071121425.09421.34427.3
2026Q4S2026-07-311121425.03421.34427.3
2026Q4S2026-07-151100423.97418.69429
2026Q4S2026-07-101110423.97418.69429
2026Q4S2026-06-301110423.98418.69429
2026Q4S2026-05-221120423.98418.69429
2026Q4S2026-05-111120423.75418.69429
2026Q4S2026-05-011190423.75418.69429

Estimate history

EPS, annual0.5490.7790.097-0.1780.8451.2921.6182.0272.1252.6637
Period201720182019202020212022202320242025TTM
EPS, quarterly0.4780.4610.4920.5380.4630.6330.6830.6470.701
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual728.129882.617994.275963.8391080.3431147.3981253.2851354.3741514.731612.95
Period201720182019202020212022202320242025TTM
Sales, quarterly339.136354.567354.33381.953384.263394.184382.394419.486416.886
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual50.24854.89355.21355.62356.5757.30657.85858.74359.42459.898
Period201720182019202020212022202320242025MRQ
Shares, quarterly58.27458.74359.07859.21859.2959.42459.65559.7159.898
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1,612.951,514.731,354.371,253.291,147.401,080.34963.84994.27882.62
Cost of Goods Sold Incl. D&A816.00777.79713.83731.05678.85640.03620.01572.87488.34
Gross Profit796.95736.94640.55522.23468.55440.31343.83421.40394.27
Selling, General and Administrative Excl. Other578.31552.57487.20400.30369.63357.41296.68382.29330.25
Research and Development96.9397.3587.4782.7375.5171.2557.5465.6159.53
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income218.64184.38153.35121.9398.9282.9047.1539.1264.02
Interest Expense32.3426.4632.8818.066.333.759.1214.4511.90
Unusual Expense6.141.09-1.521.5212.5819.0849.6724.351.76
Net Income Before Taxes211.71170.94149.99112.0982.6353.92-13.232.1949.52
Income Taxes51.5942.4529.6417.688.115.46-3.39-3.267.50
Consolidated Net Income160.12128.49120.3694.4174.5248.45-9.845.4542.02
Net Income From Continuing Operations160.12128.49120.3694.4174.5248.45-9.845.4542.02
Net Income160.12128.49120.3694.4174.5248.45-9.845.4542.02
EPS (Recurring)2.722.142.011.641.441.080.450.400.80
EPS (Basic, Before Extraordinaries)2.692.172.071.641.310.86-0.180.100.80
EPS (Diluted)2.662.132.031.621.290.84-0.180.100.78
EBITDA355.12319.03268.08223.22191.12178.68153.97143.47133.57
Non-Operating Income (Expense)31.5514.1128.009.742.62-6.15-1.591.88-0.85
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense35.8634.3322.4916.8514.2511.7510.476.854.83
Price To Earnings Ratio32.9732.9747.3844.1465.8973.83-334.9871.97
Price To Sales Ratio3.233.524.243.543.553.313.191.773.41
Gross Margin49.4148.6547.2941.6740.8440.7635.6742.3844.67
Operating Margin13.5612.1711.329.738.627.674.893.937.25
Net Margin9.938.488.897.536.494.49-1.020.554.76
Shares Outstanding59.9059.4258.7457.8657.3156.5755.6255.2154.89
Market Capitalization5,261.145,261.145,636.784,386.734,019.653,517.363,083.441,723.623,060.29

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue416.89419.49382.39394.18384.26381.95354.33354.57
Cost of Goods Sold Incl. D&A214.55204.72198.00198.74197.75197.73182.80181.16
Gross Profit202.33214.77184.40195.45186.52184.22171.53173.40
Selling, General and Administrative Excl. Other141.50154.62140.82141.37143.77137.46120.76133.17
Research and Development22.3925.3922.6126.5423.9724.3722.4825.19
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income60.8360.1543.5854.0842.7546.7650.7740.24
Interest Expense7.3312.126.536.366.756.786.577.99
Unusual Expense2.401.901.510.340.76-1.2010.380.69
Net Income Before Taxes55.7851.3153.5551.0638.5443.3837.9633.15
Income Taxes13.4712.5112.5513.0510.7910.807.815.20
Consolidated Net Income42.3138.8040.9938.0127.7532.5830.1527.95
Net Income From Continuing Operations42.3138.8040.9938.0127.7532.5830.1527.95
Net Income42.3138.8040.9938.0127.7532.5830.1527.95
EPS (Recurring)0.730.670.700.640.470.520.610.47
EPS (Basic, Before Extraordinaries)0.710.650.690.640.470.550.510.48
EPS (Diluted)0.700.650.680.630.460.540.490.46
EBITDA95.6794.1276.9388.4176.9980.5683.0471.83
Non-Operating Income (Expense)4.685.1818.003.693.312.204.141.60
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense10.7610.207.087.8213.2010.558.817.52
Price To Earnings Ratio32.9729.9332.4245.1142.2945.8552.0947.38
Price To Sales Ratio3.232.632.683.493.383.964.674.33
Gross Margin48.5351.2048.2249.5848.5448.2348.4148.91
Operating Margin14.5914.3411.4013.7211.1312.2414.3311.35
Net Margin10.159.2510.729.647.228.538.517.88
Shares Outstanding59.9059.7159.6659.4259.2959.2259.0858.74
Market Capitalization5,261.144,136.474,096.645,225.844,928.815,524.626,219.415,636.78

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments448.50378.81589.1460.5667.7556.9244.3267.3632.34
Short Term Receivables223.61209.17189.26178.45172.84157.96168.53149.99116.18
Inventories333.70306.06303.87265.99221.92198.02225.70197.54155.29
Other Current Assets34.3329.7326.2024.0919.7016.8115.9914.9512.32
Total Current Assets1,040.15923.771,108.47529.08482.21429.71454.54429.83316.12
Net Property, Plant & Equipment516.00451.67446.57448.24437.57460.97459.03331.45292.82
Total Investments and Advances29.4123.9019.2819.080.180.421.665.920.00
Long-Term Note Receivable16.259.423.242.40-----
Intangible Assets1,044.49961.78708.12635.69681.01731.45798.50798.15465.47
Deferred Tax Assets7.0516.047.296.606.084.603.793.002.36
Other Assets32.5732.0232.2722.8841.2437.2539.8051.6635.04
Total Assets2,685.922,418.602,325.241,663.971,648.291,664.401,757.321,620.011,111.81
Short Term Debt Incl. Current Port. of LT Debt10.8810.3312.0922.2519.1120.4019.0522.0019.46
Accounts Payable60.5568.5065.9468.5055.6249.8454.6254.0234.93
Income Tax Payable8.853.495.096.702.542.822.803.152.30
Other Current Liabilities159.49134.08120.45123.19159.01111.94105.1896.1758.93
Total Current Liabilities239.76216.40203.56220.65236.28185.00181.66175.34115.62
Long Term Debt810.70784.33879.27246.50295.92414.66504.70373.15259.01
Provision for Risks Charges2.252.121.911.910.931.021.993.012.75
Deferred Tax Liabilities19.660.245.5518.4631.5033.3145.2456.3623.29
Other Liabilities29.2536.1532.9532.0543.8671.8373.8079.3732.41
Total Liabilities1,101.621,039.241,123.24519.57608.50705.82807.38687.24433.07
Non-Equity Reserves0.000.000.000.000.000.000.000.002.40
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,584.301,379.361,202.001,144.401,039.80958.58949.94932.77676.33
Total Shareholders Equity1,584.301,379.361,202.001,144.401,039.80958.58949.94932.77676.33
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity1,584.301,379.361,202.001,144.401,039.80958.58949.94932.77676.33
Total Liabilities & Stockholders Equity2,685.922,418.602,325.241,663.971,648.291,664.401,757.321,620.011,111.81
Book Value Per Share26.6623.4820.7719.9718.3817.2317.2116.9913.46
Tangible Book Value Per Share9.087.118.548.886.344.082.742.454.20
Full-Time Employees7,5007,4006,9506,8466,4465,9896,3555,7834,876
Price to Book Ratio3.014.263.573.693.393.221.813.283.25
Return on Assets5.035.074.734.502.93-0.580.323.082.68
Return on Equity8.679.338.056.824.85-1.030.585.224.69
Return on Invested Capital5.365.564.545.363.63-0.720.373.222.94
Quick Ratio2.952.853.951.191.101.251.261.321.39
Current Ratio4.344.275.452.402.042.322.502.452.73

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income160.12128.49120.3694.4174.5248.45-9.845.4542.02
Depreciation136.48134.65114.73101.2992.2095.78106.82104.3669.55
Other Funds (Non Cash)42.8152.3637.5332.1133.9025.4645.3536.178.86
Funds from Operations344.62320.71257.74215.17185.69165.07131.03133.54122.48
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-70.88-23.34-36.95-70.02-71.40-17.8434.24-55.73-35.94
Income Taxes Payable8.965.23-1.78-1.694.52-0.12-0.09-0.350.92
Cash from Operating Activities273.74297.37220.80145.15114.29147.23165.2777.8186.53
Capital Expenditures-73.24-84.84-38.04-36.70-48.20-30.77-49.28-81.50-66.34
Net Assets From Acquisitions-114.98-144.77-320.18-138.28-9.26-7.17-10.95-53.90-301.79
Sale of Fixed Assets and Businesses25.560.300.010.630.071.041.330.920.06
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses-12.39-18.08-10.43-1.000.00-2.250.000.00-10.75
Other Sources0.000.000.000.000.002.000.250.000.00
Cash from Investing Activities-175.05-247.39-368.65-175.35-57.40-37.16-58.65-134.48-378.82
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock22.3128.2140.9115.5820.0721.316.636.25214.63
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock22.3128.2140.9115.5820.0721.316.636.25214.63
Proceedsfrom Stock Options22.3128.2140.9115.5820.0721.316.636.25214.63
Issuance or Reduction of Debt, Net0.000.00-99.06618.90-44.94-108.50-88.3843.02116.50
Change in Long Term Debt0.000.00-99.06618.90-44.94-108.50-88.3843.02116.50
Issuance of Long Term Debt0.000.000.001,198.53215.2198.4268.62245.18639.11
Reduction of Long Term Debt0.000.00-99.06-579.62-260.14-206.92-157.00-202.16-522.61
Net Financing Active Other Cash Flow-10.97-12.21-1.85-75.22-35.39-11.24-13.97-15.74-2.85
Other Financing Activities Uses-10.97-12.21-1.85-75.22-35.39-11.24-13.97-15.74-2.85
Cash from Financing Activities11.3316.00-60.01559.27-60.26-98.44-95.7133.53328.28
Exchange Rate Effect1.213.80-2.52-0.48-3.83-0.801.680.10-0.97
Net Change in Cash111.2369.78-210.38528.59-7.1910.8312.60-23.0435.02
Free Cash Flow203.59215.66185.66110.8669.26119.29119.28-0.3623.21
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow25.5724.7130.9339.9858.8029.9625.80-129.69
Deferred Taxes & Investment Tax Credit-5.21-14.87-12.64-14.92-4.63-11.29-12.442.05

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments505.79450.91490.25448.50394.61343.87
Short Term Receivables264.02250.90227.00223.61231.51224.24
Inventories391.02374.11352.39333.70326.55323.31
Other Current Assets37.9836.3232.1434.3332.8731.65
Total Current Assets1,198.821,112.241,101.771,040.15985.53923.07
Net Property, Plant & Equipment521.73520.52520.33516.00506.50499.26
Total Investments and Advances27.7628.2528.5629.4126.8126.80
Intangible Assets1,128.341,151.801,015.431,044.491,045.831,066.71
Deferred Tax Assets7.277.207.087.0516.2816.24
Other Assets9.7021.9124.1132.5728.8532.95
Total Assets2,924.912,863.622,719.282,685.922,631.002,586.05
Short Term Debt Incl. Current Port. of LT Debt10.3810.9211.2310.8810.6110.26
Accounts Payable66.2970.7467.8560.5564.7569.07
Income Tax Payable14.3911.0915.288.857.746.04
Other Current Liabilities174.02172.19122.52159.49147.38140.20
Total Current Liabilities265.08264.93216.87239.76230.47225.57
Long Term Debt811.68809.20810.34810.70810.54810.29
Provision for Risks Charges2.252.252.252.252.172.17
Deferred Tax Liabilities37.2239.7019.6619.6626.7126.93
Other Liabilities64.1367.7343.4429.2531.7033.04
Total Liabilities1,180.361,183.821,092.561,101.621,101.591,098.00
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,744.551,679.801,626.731,584.301,529.411,488.05
Total Shareholders Equity1,744.551,679.801,626.731,584.301,529.411,488.05
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity1,744.551,679.801,626.731,584.301,529.411,488.05
Total Liabilities & Stockholders Equity2,924.912,863.622,719.282,685.922,631.002,586.05
Book Value Per Share29.1328.1327.2726.6625.8025.13
Tangible Book Value Per Share10.298.8410.259.088.167.11
Full-Time Employees---7,500--
Price to Book Ratio3.012.542.593.423.313.87
Return on Assets5.765.345.375.034.734.81
Return on Equity9.789.199.128.678.308.60
Return on Invested Capital1.661.561.681.591.191.42
Quick Ratio3.052.793.462.952.862.66
Current Ratio4.524.205.084.344.284.09

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income42.3138.8040.9938.0127.7532.58
Depreciation34.8433.9733.3534.3334.2433.80
Other Funds (Non Cash)16.1515.27-1.6012.9915.3312.43
Funds from Operations93.3088.0472.7590.5377.3378.82
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-28.02-18.76-32.077.97-2.354.49
Income Taxes Payable4.10-4.357.461.751.95-0.38
Cash from Operating Activities65.2769.2840.6898.5174.9883.31
Capital Expenditures-13.02-18.19-16.77-25.26-23.47-14.59
Net Assets From Acquisitions-0.05-92.00-1.00-21.93-0.28-121.56
Sale of Fixed Assets and Businesses0.000.0625.500.010.000.29
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses-9.240.000.00-3.15-0.32-7.50
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-22.32-110.137.73-50.34-24.07-143.35
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock11.651.852.776.032.176.86
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock11.651.852.776.032.176.86
Proceedsfrom Stock Options11.651.852.776.032.176.86
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.04-0.90-9.06-0.97-2.53-2.52
Other Financing Activities Uses-0.04-0.90-9.06-0.97-2.53-2.52
Cash from Financing Activities11.610.95-6.295.06-0.364.35
Exchange Rate Effect0.310.57-0.430.750.092.02
Net Change in Cash54.88-39.3441.7053.9950.65-53.68
Free Cash Flow52.9351.9524.6774.0552.5469.56
Price to Free Cash Flow25.5720.4818.7324.5324.1129.46

Revenue breakdown

Cardiac Intervention2024: 368.95M 2025: 448.91M
Custom Procedural Solutions2024: 200.03M 2025: 209.33M
Endoscopy Devices2024: 54.77M 2025: 72.86M
OEM2024: 199.99M 2025: 204.96M
Peripheral Intervention2024: 532.77M 2025: 579.84M
Non-US2024: 555.73M 2025: 606.44M
United States2024: 800.78M 2025: 909.47M
Cardiovascular2024: 1.30B 2025: 1.44B
Endoscopy2024: 54.77M 2025: 72.86M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-306.85%4.0M58.4M777.12K
2026-10-156.52%3.8M58.2M795.99K
2026-09-306.24%3.6M58.2M802.70K
2026-09-156.77%3.9M58.2M871.83K
2026-08-316.22%3.6M58.2M885.04K
2026-08-145.94%3.5M58.2M898.53K
2026-07-316.43%3.7M58.2M880.69K
2026-07-155.92%3.4M58.1M811.65K
2026-06-305.84%3.4M58.1M797.55K
2026-06-155.15%3.0M58.1M783.77K
2026-05-295.07%2.9M58.1M807.33K
2026-05-154.95%2.9M58.1M826.41K
2026-04-305.57%3.2M58.2M740.72K
2026-04-155.07%2.9M58.2M738.60K
2026-03-315.26%3.1M58.0M803.30K
2026-03-135.83%3.4M58.0M736.05K
2026-02-276.12%3.6M58.0M683.79K
2026-02-136.45%3.7M58.0M684.23K
2026-01-306.59%3.8M57.9M701.66K
2026-01-156.48%3.7M57.9M677.93K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call45.0041.3045.300.003.7400.000.000.927-0.4060.019
call50.0036.3040.300.003.2600.000.000.916-0.3940.021
call55.0031.3035.300.002.8250.000.000.903-0.3810.024
call60.0026.3030.300.002.4240.000.000.887-0.3640.026
call65.0021.3025.400.002.0830.000.000.868-0.3440.029
call70.0016.3020.400.001.7240.000.000.843-0.3200.033
call75.0011.3015.300.001.3500.000.000.809-0.2910.037
call80.006.4010.400.001.0320.000.000.752-0.2620.043
call85.001.706.003.500.7901.000.000.641-0.2330.051
call90.000.001.401.420.3988.000.000.415-0.1610.053
call95.000.000.900.320.5692020.000.225-0.1410.041
call1000.002.201.000.78621.000.000.166-0.1540.034
call1050.002.150.000.9750.000.000.141-0.1700.031
call1100.002.150.001.1450.000.000.125-0.1830.028
call1150.002.150.001.3010.000.000.113-0.1940.026
call1200.001.800.001.4460.000.000.104-0.2040.025
call1250.002.150.001.5140.000.000.086-0.1850.022
call1300.002.150.001.6370.000.000.081-0.1910.021
put45.000.002.150.002.9920.000.00-0.048-0.2300.014
put50.000.002.150.002.7770.000.00-0.063-0.2660.017
put55.000.002.150.002.3930.000.00-0.073-0.2570.019
put60.000.002.150.002.0400.000.00-0.085-0.2450.021
put65.000.002.150.001.7080.000.00-0.100-0.2320.024
put70.000.002.150.001.6900.000.00-0.157-0.3130.033
put75.000.002.150.001.3480.000.00-0.191-0.2820.037
put80.000.002.301.451.0431.000.00-0.248-0.2530.043
put85.000.002.801.250.78111.000.00-0.359-0.2230.051
put90.000.504.902.700.7081.000.00-0.585-0.1510.053
put95.004.908.900.000.8310.000.00-0.775-0.1310.041
put1009.7013.800.001.0580.000.00-0.834-0.1420.034
put10514.7018.800.001.2750.000.00-0.859-0.1590.031
put11019.7023.800.001.4690.000.00-0.875-0.1710.028
put11524.7028.800.001.6460.000.00-0.887-0.1820.026
put12029.7033.800.001.8090.000.00-0.896-0.1900.025
put12534.7038.800.001.9610.000.00-0.903-0.1980.024
put13039.7043.800.002.1030.000.00-0.908-0.2040.023

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-298-KCurrent report2026-10-29SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-013Initial statement of beneficial ownership of securities2026-08-31SEC
2026-08-254Statement of changes in beneficial ownership of securities2026-08-24SEC
2026-08-254Statement of changes in beneficial ownership of securities2026-08-24SEC
2026-08-24144Filing for proposed sale of securities under Rule 144.SEC
2026-08-208-KCurrent report2026-08-14SEC
2026-08-054Statement of changes in beneficial ownership of securities2026-08-04SEC
2026-08-04144Filing for proposed sale of securities under Rule 144.SEC
2026-07-3010-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-308-KCurrent report2026-07-30SEC
2026-06-29S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-06-2611-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2025-12-31SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-05-29SDSpecialized Disclosure ReportSEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-18SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-18SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-18SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-18SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-18SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-18SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-18SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-18SEC
2026-05-193Initial statement of beneficial ownership of securities2026-05-13SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-18SEC
2026-05-198-KCurrent report2026-05-13SEC
2026-05-15S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-08002.50M2
2026-070000
2026-060000
2026-05573.29K5313.04K1
2026-040000
2026-030000
2026-020000
2026-0100450.00K1
2025-120000
2025-11005.19M4

Institutional holders

Manager% owned
TUDOR INVESTMENT CORP ET AL76.27%
ABSOLUTE INVESTMENT ADVISERS, LLC25.12%
BlackRock, Inc.15.87%
STATE OF WISCONSIN INVESTMENT BOARD6.79%
VANGUARD PORTFOLIO MANAGEMENT LLC5.82%
VANGUARD CAPITAL MANAGEMENT LLC4.34%
STATE STREET CORP4.15%
DIMENSIONAL FUND ADVISORS LP2.77%
GEODE CAPITAL MANAGEMENT, LLC2.71%
FULLER & THALER ASSET MANAGEMENT, INC.2.70%

Funds

Fund% owned
NYLIM MacKay Convertible Fund39.29%
Invesco Equity and Income Fund25.50%
iShares Convertible Bond ETF25.27%
Columbia Convertible Securities Fund22.61%
NYLIM VP MacKay Convertible Portfolio21.38%
State Street(R) SPDR(R) Bloomberg Convertible Securities ETF18.44%
Calamos Market Neutral Income Fund16.76%
Miller Market Neutral Income Fund14.25%
Fidelity Convertible Securities Fund7.99%
iShares Core S&P Small-Cap ETF6.02%

OakChart. MMSI. Cached 15 minutes.